RPL29P32

Across TCGA pan-cancer cohorts, RPL29P32 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPL29P32 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RPL29P32 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL29P32 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

HNSC, THYM, and ESCA are the cancer types where RPL29P32 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.177	0.716	<.001	54	view →
THYM	DFS	Tertile	All	0.075	0.872	<.001	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
LGG	DFS	Tertile	All	0.346	0.744	<.001	36	view →
SKCM	DFS	Tertile	IV	0.026	0.477	<.001	27	view →
THCA	OS	Tertile	All	0.240	0.931	.002	18	view →
TGCT	DFS	Tertile	All	0.151	0.801	.026	18	view →
LAML	DFS	Tertile	All	0.208	0.456	.024	18	view →
LUSC	OS	Tertile	III,IV	0.099	0.674	<.001	18	view →
KIRC	DFS	Tertile	III,IV	0.167	0.485	.015	12	view →
LUAD	DFS	Tertile	All	0.899	0.656	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPL29P32–HNSC (OS)

Open the HNSC breakdown →